PTC Therapeutics
PTCT
#2990
Rank
$5.42 B
Marketcap
$64.96
Share price
-1.50%
Change (1 day)
7.11%
Change (1 year)

PTC Therapeutics (PTCT) - Net assets

Net assets on the balance sheet as of June 2026 : -$0.17 Billion USD

According to PTC Therapeutics 's latest financial reports the company has -$0.17 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

PTC Therapeutics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-$0.21 Billion-81.3%
2024-12-31$-$1.1 Billion34.15%
2023-12-31$-$0.82 Billion135.84%
2022-12-31$-$0.35 Billion-24236.72%
2021-12-31$$1.43 M-99.7%
2020-12-31$$0.48 B-18.9%
2019-12-31$$0.59 B69.46%
2018-12-31$$0.35 B124.2%
2017-12-31$$0.15 B30.82%
2016-12-31$$0.11 B-47.09%
2015-12-31$$0.22 B-24.28%
2014-12-31$$0.29 B118.59%
2013-12-31$$0.13 B-811.36%
2012-12-31$-$19.2 Million-91.96%
2011-12-31$-$0.24 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
$41.94 B-25,466.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
$20.24 B-12,344.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
$0.50 B-404.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$1.52 B-1,023.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
$0.15 B-192.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
$1.68 B-1,121.15%๐Ÿ‡บ๐Ÿ‡ธ USA